&nbsp;

RadiationTreatment-QBP-FrequentlyAskedQuestions.pdf

Mar 2022

Document

neilJohnson.jpg

Mar 2022

Regimen

NPAC(W)+PERTRAS(SC)

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Metastatic Breast Cancer

Drugs Used:

PERTuzumab / trastuzumab (subcut) (Unfunded),

nab-PACLitaxel (Unfunded with exceptions)

Quick Link(s):

Regimen Monograph

May 2022

Regimen

NPAC+PERTRAS(SC)

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Metastatic Breast Cancer

Drugs Used:

PERTuzumab / trastuzumab (subcut) (Unfunded),

nab-PACLitaxel (Unfunded with exceptions)

Quick Link(s):

Regimen Monograph

May 2022

Document

RadiationTreatmentProgram23-24-EN-FR.pdf

Jul 2022

Regimen

NIVL

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab - Adjuvant Treatment of Urothelial Carcinoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Aug 2024

Guidelines and Advice

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Status: Current
ID: GL 2-33
Version: 2

Jun 2025

Document

RadiationTreatmentProgramSummary-FR.pdf

Nov 2022

Regimen

NIVL(MNT)

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Aug 2024

Document